For example, Fascin is applied as a marker for mature DCs in anticancer therapies that target DCs, where isolation of pure DCs is a crucial requirement [14], while loss of Fascin-positive DCs in follicular lymphomas has been suggested to contribute to the clinical prognosis [15]. Here, FSCN1 is linked to follicular lymphoma.